News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Signet Therapeutics receives FDA IND approval for the first targeted therapy designed for Diffuse Gastric Cancer
Tuesday, July 02, 2024Signet Therapeutics a biotech company specializing in organoid disease models and AI for targeted cancer therapy announced FDA approval of its Investigational New Drug application for sigx
Taurx Pharmaceuticals Has Applied for Marketing Authorisation in the UK for HMTM as an Alzheimer's Treatment
Monday, July 01, 2024TauRx Pharmaceuticals Ltd has submitted a UK Marketing Authorisation Application for hydromethylthionine mesylate targeting mild cognitive impairment and mild
Waypoint Bio Raises $14.5 Million to Enhance Drug Discovery Through in vivo Spatial Pooled Screening Technology
Saturday, June 29, 2024Waypoint Bio a biotechnology company has secured million in seed funding led by Hummingbird Ventures with participation from Recode Ventures and Fifty Years The company focuses on developing
AQEMIA and Servier Reach Milestone in Immuno-Oncology Targeting Challenging Conditions
Saturday, June 29, 2024AQEMIA a leader in AIdriven drug discovery has achieved a significant research milestone in collaboration with Servier an international pharmaceutical company targeting an unmanageable
Bayer and Rad AI Collaborate to Advance Radiology through AI
Friday, June 28, 2024Bayer and Rad AI have announced a new partnership at the SIIM conference focusing on integrating Rad AIs AIdriven radiology operational solutions into Bayers Calantic Digital Solutions platform Rad AI provides advanced technologies like radiology spe...
ReCode Therapeutics Receives FDA Orphan Drug Designation for RCT1100 Targeting Primary Ciliary Dyskinesia
Friday, June 28, 2024ReCode Therapeutics announced today that the US Food and Drug Administration has granted Orphan Drug Designation to RCT for the treatment of primary ciliary dyskinesia This genetic disease
Skyhawk Therapeutics Launches Cutting-Edge Laboratories in Basel, Switzerland
Thursday, June 27, 2024Skyhawk Therapeutics Inc a clinicalstage biotech company focused on developing innovative small molecule therapies that target critical RNA molecules has announced its expansion
InDevR Introduces 5'CapQ for Quick Assessment of mRNA Vaccine Quality Attributes
Wednesday, June 26, 2024InDevR Inc a leader in vaccine analytical solutions has introduced CapQ a new kit designed for rapid determination of mRNA capping efficiency This solution part of the VaxArray Platform
ProBio Expands Plasmid DNA and Viral Vector Production Facility in New Jersey to Speed Up Delivery of Cell and Gene Therapies
Wednesday, June 26, 2024ProBio Inc a prominent contract development and manufacturing organization based in New Jersey has inaugurated a stateoftheart facility in Hopewell New Jersey aimed at expanding its capabilities
Navamedic and Orion Corporation Form License & Supply Agreement for Flexilev® in Europe
Tuesday, June 25, 2024Navamedic ASA and Orion Corporation have signed an exclusive license and supply agreement for Flexilev and its OraFID dispenser in most of Europe excluding Sweden Norway Denmark and Iceland
